Search All News
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
- May 19, 2017
Neurosurgeon Sameer Sheth uses deep brain stimulation to treat depression in patients who have not been helped with other therapies.
- May 15, 2017
Spinal muscular atrophy is partly due to defects in the sensory neuron synapses that activate motor neurons. Symptoms may be reduced by improving synapse function.
- May 10, 2017
Columbia neurologist Melodie Winawer talks about her debut novel, "The Scribe of Siena," and the parallels between science and writing historical fiction.
- May 3, 2017
Columbia scientists observed how molecules that regulate chemical signaling in the brain interact with the AMPA receptor, governing brain function.
- February 28, 2017
In a study of athletes at Columbia University, researchers found that women may be more susceptible to concussions than men.
- January 19, 2017
Columbia researchers have linked excess tau protein in the brain to the spatial disorientation that leads to wandering in many Alzheimer's disease patients.
- January 13, 2017
Columbia and NewYork-Presbyterian research has shown that several genes implicated in rare forms of pediatric epilepsy also contribute to common forms of the disorder.
- December 2, 2016
Wolfgang Pernice hunts for the gene that caused his neuromuscular disorder and hopes it will help lead to better treatments for others with Charcot Marie Tooth Disease.